Thursday, June 13, 2019
| 0700 | Breakfast and Registration | |
| 0745 | Welcome remarks Sunil Verma and Jaime Escallon |
|
| Chair: Sunil Verma and Jaime Escallon | ||
| 0800 | Key Note Lecture:
Addressing challenges and opportunities as we strive to de-escalate treatment for breast cancer |
|
| Chairs: Anne Koch and Eileen Rakovitch | ||
| 0845 | De-escalation of radiation for node positive breast cancer Jennifer Bellon |
|
| 0915 | DCIS Lawrence Solin |
|
| 0945 | Break with exhibitors | |
| Chair: Ellen Warner | ||
| 1000 | Multi-gene signatures in breast cancer: current evidence and controversies Stephen Chia |
|
| 1015 | Guidelines update: AJCC 8th Edition and new ASCO/CAP guidelines on Her 2 Testing Susan Done |
|
| 1030 | Management of patients with high and moderate risk germline mutations Andrea Eisen |
|
| 1045 | Chair Sunil Verma | |
| Forum: What’s needed next to meet the challenges in breast cancer care? | ||
| 1045 | Clinician perspective: Ellen Warner |
|
| 1100 | Researcher perspective: John Bartlett |
|
| 1115 | Funding Perspective: Maureen Trudeau |
|
| 1130 | Patient perspective: MJ DeCoteau and Vesna Zic-Cote |
|
| 1145 | Panel discussion with audience | |
| 1200 | Lunch with exhibitors | |
| Chair: Maureen Trudeau | ||
| 1300 | Debate: Immuno-therapy in breast cancer is ready for clinical use?
|
|
| 1330 | New advances in TNBC Breast Ca David Cescon |
|
| 1345 | New advances in Her 2 Positive Breast Ca Sunil Verma |
|
| 1400 | New advances in ER Positive Breast Ca Christine Brezden-Masley |
|
| 1415 | Panel discussion with audience Panelists: David Cescon / John Hilton/Karen Gelmon / Christine Brezden-Masley / SunilVerma |
|
| 1445 | Break with exhibitors | |
| Case Discussion Chairs: Nadia Califaretti and Mala Bahl | ||
| 1515 | Biosimilars in breast cancer: trials, economics and potential for reinvestment Eitan Amir |
|
| Chair: Pamela Goodwin | ||
| Neoadjuvant treatment for breast cancer – The new reality | ||
| 1530 | Medical Oncologist Perspective: Christine Simmons |
|
| 1540 | Surgical Oncologist: Ralph George |
|
| 1550 | Radiation Oncologist: Anne Koch |
|
| 1600 | Panel discussion with audience | |
| Chair: Pamela Goodwin and Sunil Verma | ||
| 1615 | Keynote Lecture The Canadian Impact on Breast Cancer Research and Care Karen Gelmon |
|
Friday June 14, 2019
| 0615 | Breakfast and registration |
| 0700 | Breakfast symposium: Tips and Tricks in Oncoplastic Surgery Tulin Cil & Muriel Brackstone |
| Chair: Tulin Cil | |
| 0800 | Robotic assisted nipple and skin sparing mastectomy Antonio Toesca |
| Chair: Andrea Eisen | |
| 0900 | Canadian Task Force on Breast Cancer Screening: Perspective Martin Yaffe |
| 0940 | Contemporary management of Phyllodes Lesions Frances Wright |
| 1000 | What to do with high risk lesions? ADH, Radial Scar, DCIS
|
| 10:20 | Panel with Martin Yaffe, Frances Wright, Claire Holloway, Erin Cordeiro |
| 1030 | Break with exhibitors |
| Chair: Alexandra Easson | |
| 1045 | Management of recurrence after lumpectomy Is mastectomy always necessary? Amanda Roberts |
| 1100 | The evolving role for MRI and novel imaging techniques in screening and care of breast cancer patients Allison Grant |
| 1115 | Advances in localization techniques: wire, mag seeds, radioactive seeds Nicole Look-Hong |
| 1130 | Strategies to achieve negative margins Wey Leong |
| 1145 | Is Chronic Pain after Breast Surgery a real problem? David Flamer |
| 1200 | Lunch Surgical Oncology and Breast Fellows meet with Antonio Toesca |
| Chair: Jaime Escallon | |
| 1300 | Novel surgical management of lymphedema Syba Haykal |
| 1330 | Therapeutic opportunities in macrophage-induced breast cancer progression Michael Reedjik |
| Afternoon Streams | |
| 1400-1600 |
See agenda below |
Research Symposium
Frontenac Room (plenary room)
| 1400 | Welcome Remarks Amanda Roberts |
| 1405 | Psychosocial Functioning in Women with Early Breast Cancer Treated with Breast Surgery With or Without Immediate Breast Reconstruction Helene Retrouvey |
| 1410 | Do No Harm and yet Respect Patient Autonomy: Plastic Surgeons’ Perspectives of the Consultation for Breast Reconstruction with Women Who Have Early Stage Breast Cancer Frances Wright |
| 1415 | Quality-of-Life and Surgical Outcome Comparison in Breast Cancer Patients treated with Oncoplastic Breast-Conserving Surgery vs Mastectomy with Immediate Reconstruction Aneesh Karir |
| 1420 | A randomised controlled trial comparing Alloderm with Dermacell in immediate implant-based breast reconstruction Erin Cordeiro |
| 1425 | Q&A with workshop participants |
| 1430 | Predictors of axillary node response in clinically node-positive patients undergoing neoadjuvant chemotherapy for breast cancer Ashley DiPasquale |
| 1435 | Impact of omitting sentinel lymph node biopsy in elderly patients with clinically node negative, ER positive breast cancer Rebecca Warburton |
| 1440 | Surgical Outcomes of Older Women with breast cancer: Data from the ACS NSQIP database Tulin Cil |
| 1445 | Disparities among breast cancer patients who do not receive their recommended surgery Ashley DiPasquale |
| 1450 | Q&A with workshop participants |
| 1455 | Patient navigation reduces time to care for patients with breast symptoms and abnormal screening mammograms Rebecca Warburton |
| 1500 | Coordination of radiologic and clinical care reduces the wait time to breast cancer diagnosis Rebecca Warburton |
| 1505 | Taking the Pulse of Multidisciplinary Cancer Conferences for Breast Cancer Care in Canada: A Stocktake of Current Practice Arden Corter |
| 1510 | A randomized controlled feasibility study comparing a multimodal prehabilitation protocol to normal care for women undergoing neo-adjuvant chemotherapy for breast cancer Frances Wright |
| 1515 | LYMPHA in Breast Cancer Patients: Present Outcomes and Next Steps Moein Momtazi |
| 1520 | Q&A with workshop participants |
| 1525 | The BEFORE (Begin Exploring Fertility Options, Risks, and Expectations) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients Brittany Speller |
| 1530 | The role of a digital breast cancer surgery decision aid in supporting breast cancer patients Jenn Gordon |
| 1535 | Jackson Pratt (JP) Drain Milking Device Improves Outcomes Following Breast Cancer Surgery Rachel Shekhman-Goldstein |
| 1540 | The outcomes of ReFilx soft tissue filler as an immediate reconstruction technique for lumpectomy followed by radiotherapy Wey Leong |
| 1545 | Development of a multimodal autofluorescence -Raman spectroscope as a diagnostic and biospy guiding tool in breast cancer Alexandra Easson |
| 1550 | Intraoperative Fluorescence Imaging with Aminolevulinic Acid Detects Grossly Occult Breast Cancer: A Phase II Randomized Controlled Trial Ralph Da Costa |
| 1555 | Q&A with workshop participants |
| 1600 | Flat Epithelial Atypia does not require excision Rebecca Warburton |
| 1605 | Flat epithelial atypia: Are we being too aggressive? Ashley DiPasquale |
| 1610 | A Survey of Canadian Breast Health Professionals’ Recommendations for High-Risk Benign Breast Disease Erin Cordeiro |
| 1615 | Closing remarks Amanda Roberts |
| 1620 | End of Day |
Primary Care Workshop
Queens Quay I
| 1400 | Welcome and Introduction Melinda Wu |
| 1405 | Breast pain Azadeh Nikoo Rajaee |
| 1425 | Genetics 101 Nicole Gojksa, Genetic Counsellor |
| 1445 | Breast density Supriya Kulkarni |
| 1505 | Panel discussion with audience |
| 1530 | Breast cancer screening Ellen Warner |
| 1550 | Survivorship care Carol Townsley |
| 1610 | HRT in Breast Cancer Jellena Wong |
| 1630 | Panel discussion with audience |
| 1645 | Wrap up Melinda Wu |
| 1700 | End of Day |
Patient Program: Rethink Workshop
Queens Quay II
(open to all delegates)
Chair: Shawna Rich-Ginsberg
Shared Decision-Making Workshop
Shared decision is a collaborative process that brings together the professional experience and clinical expertise of health care professionals and the values, perspectives and treatment goals of patients with the goal of making the right treatment decision for the patient.
While shared decision making is heralded as a gold-standard practice in patient-centred care, patients and physicians are still experiencing barriers to fully realizing its potential.
Can we improve the process and outcomes of shared decision making in treating metastatic breast cancer?
| 1400 | Welcome and Introductions Shawna Rich Ginsberg |
| 1405 | A physician’s perspective |
| 1420 | A patient’s perspective |
| 1435 | Facilitated group discussion: Improving shared decision making in treating breast cancer |
| 1515 | Breakout discussions: Small groups will discuss the needs gaps and needs to improve shared decision making in treating breast cancer from various stakeholder perspectives. |
| 1550 | Conclusion and Next Steps |
Saturday, June 15, 2019
Advanced Oncoplastic Partnership Workshop
Westin Harbour Castle Toronto, Ontario
(additional registration required, space limited)
Agenda details:
https://www.breastsymposium.ca/oncoplastic-partnership-workshop